Certificate number:RU.77.99.88.003.Е.004589.10.17
Date of registration and renewal:30.10.2017
Dosage form: & nbspCapsules weighing 598 m.
Classification "Composition" & nbsp BAD - products of plant, animal or mineral origin
Composition: & nbspRaw food Nitrosigine, capsule shell (gelatin or E464, food color E171 or E100 or E101, or E160a, or E162, or E163 or E140 or E141 or E 132), the composition of the capsule shell DRcapsTM (E464, E418, food grade E171 or E100 or E101 or E160a or E162 or E163 or E140 or E141 or E 132), extract of a marmalade, raw food L-Norvalin, dry extract of fenugreek, dry extract of long-leaved eurycoma, extract dry mummy, ginseng extract, dry licorice root extract, dried hawthorn extract, grass sponge extract, magnolia root extract Thai, yohimbe bark extract, guarana fruit extract, raw food Bioperine (black pepper extract, E460.
Scope: & nbspFor realization to the population as a biologically active food additive - a source of schisandrine, panaxosides, icarian, glycyrrhizic acid, an additional source of silicon containing saponins, yohimbine, inositol.
Suggested Usage: & nbspAdults take 2 capsules in the morning with meals. Duration of admission is 2-3 weeks. If necessary, the reception can be repeated after 1-2 months. Repeated receptions are possible throughout the year.
Contraindications:It is not recommended to use children under the age of 18, individual intolerance to the components of the product, pregnancy and lactation, hypertension, cardiac rhythm disturbances, severe atherosclerosis, insomnia, increased nervous excitability, liver and kidney disease.
Special instructions:Do not allow simultaneous administration of adrenomimetics. Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in a dry and inaccessible place for children at a temperature not exceeding + 25 ° C.
Research protocols:Expert conclusion of FGBUN "FIC of nutrition and biotechnology" №529 / Э-852 / б-17 of 05.10.2017.
Recipient:Pharmaceutical holding GI EL Medical, OOOPharmaceutical holding GI EL Medical, OOO Russian Federation
Information update date: & nbsp17.01.2018
Instructions
Up